When a Regular Asks What to Do Now: A Counter Script for Ban Week

Rebel X Brands, for licensed retailers and distributors.
Published 14 September 2026.

Thursday evening, an hour before close. A man who has bought the same thing from you every week for two years puts it on the counter. You tell him you cannot sell it any more. He does not argue and he does not shout. He asks what he is supposed to do now.

Whoever is working that shift has about thirty seconds and one sentence.

Nobody has written that sentence. Three of the five states below never did, the trade bodies have not, and neither had we, which is the reason for this piece. So the twenty year old on the register improvises, and improvised is the one thing it must not be.

This is addressed to whoever signs the purchase orders, because a counter clerk cannot build the fix alone. It costs a printer, ten minutes of a shift meeting, and a decision that the right answer is a referral rather than a sale.

The reflex to train out first

A customer says the word withdrawal and the shop reaches for the shelf. It is what a retail brain does with any problem: match the need to a product, because that is the job every other hour of the week. He is upset, you want to help, and something four feet away could go in his hand. That instinct fails twice in the same move.

The first failure is clinical. Massachusetts DPH and its Bureau of Substance Addiction Services wrote this on the state's own kratom page, before the order took effect:

These products can act like potent opioids. Therefore, people who regularly use these products are likely to experience opioid tolerance and withdrawal symptoms when they stop or reduce their use, including craving, nausea, diarrhea, muscle and head aches, sniffling, sneezing, sweating, and irritability. They should seek medical care and/or substance use treatment.

Read what that makes the man at your counter. In the state's own description a daily user of two years is opioid tolerant and heading into an opioid type withdrawal, and the same page says naloxone should be given as though a kratom overdose were an opioid overdose. Recommending any substance to a person in that condition is a clinical judgment. Your staff member is not qualified to make it. Neither are you.

Say the plain version out loud, because half this trade still will not. Kratom is not a treatment for opioid use disorder and not a treatment for opioid or kratom withdrawal. Nothing else behind your counter is one either: not kava, not another vendor's version of the same thing, not a stronger grade or a gentler one. The medicines with an evidence base are buprenorphine, methadone and naltrexone, and they are prescribed by people with licences.

The second failure is the one an operator feels later. A shop that answers a prohibition by walking its regulars across the aisle to the nearest adjacent thing visibly produces the pattern that lands a category on a governor's desk. Dr Jennifer Michaels, medical director of The Brien Center in the Berkshires, told the Berkshire Eagle on 25 August 2026, in Izzy Bryars's report, that the gas station where she buys her coffee has turned into what she called "a kratom store". That is a clinician describing retail.

A counter is not a clinic, and is not supposed to be

The correct behaviour is narrow and cheap. A shop cannot assess anybody. It cannot dose, it cannot taper, it cannot tell one person's withdrawal from another's. What a counter can do is three things that fit inside thirty seconds: say no clearly, without pretending the refusal is small; hand over a number somebody else answers; and offer to look up what exists in that state and write it down.

Refuse the clinical question out loud, then replace the refusal with something the person can carry out of the shop. A refusal on its own is a door closing. A refusal plus a card is a referral, and a referral is a thing a retail business is allowed to make.

The script

Print this and read it aloud at a shift meeting, twice, because nobody can say a sentence under pressure that they have only ever read silently. It is written for somebody nervous who does not want this conversation.

Four things are doing the work in there.

The apology comes before the refusal. Two years of weekly custom is a relationship, and a person told no by somebody they know can hear whether the no was easy to say.

The refusal is spoken, not implied. "I'm not trained for it and I'd get it wrong" is the load bearing line in the script. It closes the clinical conversation without leaving the customer feeling dismissed, and because it is honest it holds up when they push. Staff who soften it into a shrug end up answering the question anyway.

The card replaces the answer. An empty refusal makes people angry and sends them somewhere worse for information. A refusal with a physical object attached does not, and the object matters more than the wording.

The clinical sentence is quoted, not offered. Connecticut's Department of Mental Health and Addiction Services published this on its own kratom page: "Do not stop abruptly without consulting a healthcare provider." Your staff member is not giving that advice. They are reading a sentence a state wrote, naming the state, and pointing at where it is printed. That is the difference between relaying a public health instruction and issuing one.

What goes on the card

One card, business card size, in a stack under the register and in the opener's pocket. No product on it, no logo bigger than the phone numbers, no marketing copy. If it looks like an advertisement it goes in the bin at the door.

National numbers at the top, not the bottom. That is the status box turned into a design decision, and the next section is why.

Only two of the five published a page a shop could hand over

Massachusetts and Connecticut both published a page, and Connecticut went further than any state in the record, naming the ban itself as a reason somebody might now need help: "If you or someone you care about has been using kratom regularly and is now struggling, whether it is due to the recent changes in the law, physical dependence, or a desire to stop, you are not alone and help is available in Connecticut." A shop in Hartford can hand that over without adding a word.

North Dakota wrote a paragraph. The Governor's office closed its announcement of the executive action by pointing readers to 988 and 211. One paragraph is not nothing, and it is a lot less than a page. That order was rescinded on 4 September 2026 and kratom remains banned there, so the counter answer is unchanged.

Tennessee published, but not for your counter: a February 2026 surveillance brief that predates the ban, and a prevention and overdose response page. Both carry referral numbers, which is why the REDLINE is on the card. Neither addresses withdrawal management and neither was written because of the ban, so there is nothing to hand a regular who asks how to stop.

For Louisiana we could not find anything, and we are not going to upgrade that phrasing: we looked where a shop owner or customer would look and came back empty. The only state announcement was a Department of Revenue item on penalties, dated 1 August 2025. That is the tax agency.

Run a counter in Nashville or Baton Rouge and there is no transition page to point at, nothing local to hand across. The national number is not the fallback on that card. It is the card. Build it assuming your state publishes nothing.

Why nobody at your counter should paraphrase the evidence

One of your staff will have looked this up on a phone and will want to be helpful with it. Here is how thin the ground is under anyone who tries.

Established, and stated in those terms by both state health departments: physical dependence develops with regular consistent use, and an opioid type withdrawal follows when a regular user stops.

The federal research institute is more cautious, and your staff should hear it from you, not from a customer. NIDA writes that studies suggest people "may experience mild to moderate withdrawal symptoms when they stop regular kratom use, but more research is needed". Its page is dated March 2026 and still calls kratom federally unscheduled, so it is no use for legal status.

After that it thins fast. There is no agreed severity scale, no agreed timeline and no standardised protocol; the main systematic review, in the Journal of Psychoactive Drugs in 2019, is built substantially on case reports. Massachusetts states that medications used for opioid use disorder, buprenorphine among them, have been found effective here, and the citation under that sentence is Broyan and colleagues in 2022, a case series of twenty eight patients. Smith, Epstein and Weiss, in Current Psychiatry Reports in 2024, note that most clinicians select buprenorphine "although there are no controlled studies showing that buprenorphine is safe or efficacious in this patient population", and NIDA's own page says there are currently no approved medical therapies for these conditions. So: clinicians extrapolate from opioid use disorder. Emerging, not established.

One number will be misquoted at you, probably by a rep. Hill and colleagues, in the Journal of Addiction Medicine in 2024, surveyed 2,061 current consumers online and found 25.5 per cent met adapted DSM-5 criteria for kratom use disorder, most often through tolerance and withdrawal. That is an anonymous online convenience sample of current consumers, not a population prevalence estimate, so anybody compressing it into a claim about one in four users has either not read the paper or is counting on you not having read it.

If the published literature hedges this carefully, an hourly employee six weeks into the job has no business compressing it into a helpful remark at seven in the evening.

The worry in the coverage, and the only observation anybody has

You will hear a version of this in the trade, and the wrong version is false and self serving. What the record holds is two named people expressing a fear. Michaels told the Berkshire Eagle that "we may end up unintentionally putting them at risk", her stated worry being patients turning to street opioid pills or heroin or fentanyl. Julia MacDonald, who directs Living in Recovery in Pittsfield, told the same paper that "just ripping it out from under them is not necessarily the most humane approach". The Eagle's own framing is careful, and here it is in full: "But while public health officials generally agree that kratom is dangerous and addictive, some have expressed concern that cutting access without a path to treatment could push some users toward other illicit narcotics." The first clause does not help us, and it travels with the second anyway. Could. Some. Those are the paper's words, all of them.

Set against that is the one post ban observation anybody has taken. Roughly nine days after North Dakota's prohibition took effect, KXNET in Bismarck reported that the ban had not led to a spike or increase in people seeking treatment, while staffers at Heartview believed that could change if the drug were permanently banned. Nine days is a short window and one provider is a small sample, so their caveat travels with the finding. It is also the only observation of its kind anywhere, and running the warning without it is cherry picking.

Nobody knows which way this goes for the person standing in front of your employee, and that uncertainty is the argument for the card rather than against it. If the clinicians are right, the number in his pocket is the thing that mattered. If North Dakota's first fortnight is typical, the card cost you four cents.

The person on your counter is twenty and six weeks in

Describe the actual staff member rather than the one in the compliance binder. Nineteen to twenty four, part time, often alone on an evening shift, on a wage that would not cover the product they are selling. Two months in. Nobody has ever discussed dependence with them, and the training they did get was about upselling and checking identification.

That person will have this conversation whether or not you prepare them, four or five times in the fortnight after a market closes. It is not their job to invent a policy on dependence while a distressed customer waits. It is yours, and the gap between those two facts is where every bad outcome here lives.

Preparing them is not a programme. It is the printed card, the script read aloud twice, one named person they can phone if it goes badly, and an explicit statement from you that "I don't know, here is who does" is the correct answer. Add that last part deliberately: junior staff guess because they think not knowing looks bad, and only you can take that fear away.

Everything said at the counter is a record

A label goes past you before it goes out. Your website copy goes past you. A sentence spoken at the register does not, and because nobody writes it down it is easy to believe it does not exist. It does. It exists in the customer's memory, in the account he gives a relative that evening, in a complaint form, in a licensing hearing, and in whatever a reporter is told after a ban. Your business said it.

So the content of that record matters more than its existence. "We can't sell it, here is a helpline" is a record you want: short, true, identical every time. "Try this instead, it'll take the edge off" is a statement your business made about a medical outcome, by an untrained employee, unreviewed and unrepeatable in your own words later. You cannot correct it, because you will never know it happened.

So log lightly. One line in the shift notes: the date, that a customer asked about stopping, that a card was given, that no advice was offered. Do not record his name and do not write down anything he told you about his health, because you are not a clinic. What you keep is evidence that the process ran.

What to do before the next one lands

Print the card for every state you operate in, national numbers at the top and a state line underneath if the state published one. Read the script aloud at the next shift meeting and have somebody say it back. Tell your team the refusal is correct. Decide who they call when it goes badly.

Do all of it ahead of an announcement rather than after, because the notice window has been closing. North Dakota went from announcement to in force in about two business days, which we went through in the piece on collapsing lead times, and Massachusetts moved on a schedule we tracked in the Massachusetts update. Training written after the announcement gets delivered in front of the customer.

One last thing, about us rather than you. A supplier that gives its retailers no language for this conversation is leaving the hardest thirty seconds of the business to a part timer, and that is what we were doing until 1 September 2026. Ask through the contact page and we will send the card as a print ready file, whether or not you buy from us, because a card with somebody else's logo does the customer exactly as much good. If you want to talk about an account, that starts at the wholesale application.

The regular who walks up on Thursday has been your customer for two years and is about to stop being anybody's customer, which is rather the point. Nothing you sell can help him and nobody behind that counter can advise him. What you control is whether the person serving him has a number in their hand and one honest sentence ready, or is working it out from scratch while he waits.

General operational guidance for licensed retailers and distributors. Not legal advice and not medical advice, and no substitute for a clinician or for counsel in your own jurisdiction. Statements that a state published nothing mean a search on 7 September 2026 did not find anything, not that nothing exists. Rules here change quickly and vary by state, county and city, so verify the position in every market you serve. Rebel X Brands sells botanical products and is an interested party. These statements have not been evaluated by the Food and Drug Administration.